Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

149. HIV: Prevention: Friday, 12:15 - 1:30 p.m.

Poster Session: HIV: Prevention

(1558) Associations between gender identity and solicited adverse events after passive infusion of VRC01 or placebo in HVTN 704/HPTN 085

Friday, October 13, 2023
12:15 PM – 1:30 PM US ET
Location: Hall B + C

    Presenting Author(s)

  • DT

    Deborah Theodore, MD

    Assistant Professor of Medicine
    Columbia University Irving Medical Center
    New York, New York, United States

    • Co-Author(s)

  • MN

    Moni Neradilek, MS

    Statistical Research Associate
    SCHARP (Fred Hutch Cancer Center)
    Seattle, Washington, United States

  • KG

    Kevin Gillespie, MS

    SCHARP (Fred Hutch)
    Seattle, Washington, United States

  • SE

    Srilatha Edupuganti, MD MPH FIDSA

    Associate Professor
    Emory University School of Medicine
    Decatur, GA, United States

  • JH

    Juan Carlos Hinojosa, MD

    Asociacion Civil Selva Amazonica
    Iquitos, Loreto, Peru

  • JL

    Javier R. Lama, MD, MPH

    Director of Research
    Asociacion Civil Impacta Salud y Educacion
    Lima, Lima, Peru

  • RD

    Robert De La Grecca, MD

    Regional Medical Liaison
    HIV Vaccine Trials Network (HVTN) at Fred Hutchinson Cancer Research Center
    Lima, Lima, Peru

  • AD

    Annet Davis, MSW, RN

    University of Pennsylvania
    Philadelphia, Pennsylvania, United States

  • DM

    Daniel J. Mangini, B.S. Business Mgmt

    Recruitment Specialist/Clinical Research Assistant
    University of Pennsylvania
    Philadelphia, Pennsylvania, United States

  • PA

    Philip Andrew, RN

    Senior Research Clinician
    FHI 360, HIV Prevention Trials Network
    Durham, NC, United States

  • MM

    Mary Marovich, M.D.

    Director, Vaccine Research Program
    National Institute of Allergy and Infectious Diseases, National Institutes of Health
    Bethesda, Maryland, United States

  • SZ

    Sheryl Zwerski, D.N.P.

    National Institutes of Health
    Rockville, Maryland, United States

  • DC

    Delivette Castor, PhD

    Columbia University Medical Center
    New York, New York, United States

  • AR

    Alison C. Roxby, MD, MSc

    Associate Professor
    University of Washington
    Seattle, Washington, United States

  • MC

    Myron Cohen, MD

    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina, United States

  • LC

    Lawrence Corey, MD

    President and Director Emeritus
    Fred Hutchinson Cancer Research Center
    Seattle, WA, United States

  • YH

    Yunda Huang, PhD

    Fred Hutch
    Seattle, Washington, United States

  • SK

    Shelly Karuna, MD, MPH

    Chief Medical Officer & Principal Investigator
    GreenLight Biosciences & Fred Hutch Cancer Center
    Seattle, Washington, United States

  • Magdalena E. Sobieszczyk, MD, MPH

    Chief, Division of Infectious Diseases
    Division of Infectious Diseases, Department of Medicine, Vagelos College of Physicians and Surgeons, New York-Presbyterian Columbia University Irving Medical Center, New York, NY, USA
    New York, New York, United States